Drivers of peak sales for pharmaceutical brands

Quantitative Marketing and Economics

Volumn 8, Issue 4, 2010, Pages 429-460

  Fischer, Marc ^a   Leeflang, Peter S H ^b,c   Verhoef, Peter C ^b  

^a UNIVERSITY OF PASSAU   (Germany)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c LUISS UNIVERSITY   (Italy)

Author keywords

Brand growth; Econometric models; Market entry; Peak sales metrics; Pharmaceutical marketing

Indexed keywords

EID: 85015376513     PISSN: 15707156     EISSN: 1573711X     Source Type: Journal    
DOI: 10.1007/s11129-010-9089-5     Document Type: Article

References (68)

1. Agarwal, R., & Bayus, B. L. (2002). The market evolution and sales takeoff of product innovations. Management Science, 48(8), 1024-1041.
2. Ainslie, A., Drèze, X., & Zufryden, F. (2005). Modeling movie lifecycles and market share. Marketing Science, 24(3), 508-517.
3. Alpert, F. H., & Kamins, M. A. (1994). Pioneer brand advantage and consumer behavior: a conceptual framework and propositional inventory. Journal of the Academy of Marketing Science, 22(3), 244-253.
4. Bass, F. M. (1969). A new product growth model for consumer durables. Management Science, 15, 215-227.
5. Bauer, H. H., & Fischer, M. (2000). Product life cycle patterns for pharmaceuticals and their impact on R&D profitability of late mover products. International Business Review, 9(6), 703-725.
6. Bayus, B. L. (1998). An analysis of product lifetimes in a technologically dynamic industry. Management Science, 44(6), 763-775.
7. Berndt, E. R., Bui, L., Reily, D. R., & Urban, G. L. (1995). Information, marketing, and pricing in the U.S. antiulcer drug market. American Economic Review, Papers and Proceedings, 85(2), 100-105.
8. Bodapati, A., & Gupta, S. (2004). The recoverability of segmentation structure from store-level aggregate data. Journal of Marketing Research, 41(3), 351-364.
9. Boswijk, H. P., & Franses, P. H. (2005). On the econometrics of the Bass diffusion model. Journal of Business and Economic Statistics, 23, 255-268.
10. Brockhoff, K. (1967). A test for the product life cycle. Econometrica, 35(3/4), 472-484.
11. Chintagunta, P. K., Erdem, T., Rossi, P. E., & Wedel, M. (2006). Structural modeling in marketing: review and assessment. Marketing Science, 26(6), 604-616.
12. Cooper, L. G., & Nakanishi, M. (1988). Market-share analysis: Evaluating competitive marketing effectiveness. Boston: Kluwer Academic.
13. Corstjens, M., Demeire, E., & Horowitz, I. (2005). New product success in the pharmaceutical industry: how many bites at the cherry? Economics of Innovation and New Technology, 14(4), 319-331.
14. Cox, W. E. (1967). Product life cycles as marketing models. Journal of Business, 40(4), 375-384.
15. Datamonitor (2007). Orthovita: Cortoss could generate high sales in the spinal fracture market, http://www.datamonitor.com/companies/company/?pid=6FB42625-9E2A-4DB4-82B1-26875E2D5B7C&nid=1AE201D1-E6E5-4EAD-85F2-205968C4FA11&type=CommentWire&article=1 (Accessed at 1/22/2008).
16. Dhalla, N. K., & Yuspeh, S. (1976). Forget the product life cycle concept! Harvard Business Review, 54(1), 102-111.
17. Dubé, J. P., & Manchanda, P. (2005). Differences in dynamic brand competition across markets: an empirical analysis. Marketing Science, 24(1), 81-95.
18. Fischer, M., & Albers, S. (2010). Patient- or physician-oriented marketing: what drives primary demand for prescription drugs? Journal of Marketing Research, 47(1), 103-121.
19. Fok, D., & Franses, P. H. (2007). Modeling the diffusion of scientific publications. Journal of Econometrics, 139, 376-390.
20. Franses, P. H. (2005). Diagnostics, expectations, and endogeneity. Journal of Marketing Research, 42(1), 27-29.
21. Gielens, K., & Dekimpe, M. G. (2001). Do international entry decisions of retail chains matter in the long run? International Journal of Research in Marketing, 18(3), 235-259.
22. Gielens, K., & Steenkamp, J. B. E. M. (2007). Drivers of consumer acceptance of new packaged goods: An investigation across products and countries. International Journal of Research in Marketing, 24(2), 97-112.
23. Goldenberg, J., Libai, B., & Muller, E. (2002). Riding the saddle: how cross-market communications can create a major slump in sales. Journal of Marketing, 66(2), 1-16.
24. Golder, P. N., & Tellis, G. J. (1993). Pioneer advantage: marketing logic or marketing legend? Journal of Marketing Research, 30(2), 158-170.
25. Golder, P. N., & Tellis, G. J. (1997). Will it ever fly? Modeling the takeoff of really new consumer durables. Marketing Science, 16(3), 256-270.
26. Golder, P. N., & Tellis, G. J. (2004). Growing, growing, gone: cascades, diffusion, and turning points in the product life cycle. Marketing Science, 23(2), 207-218.
27. Grabowski, H., & Vernon, J. (1990). A new look at the returns and risks to pharmaceutical R&D. Management Science, 36(7), 804-821.
28. Greene, W. H. (2004). Econometric analysis (5th ed.). Upper Saddle River: Prentice Hall.
29. Hahn, M., Park, S., Krishnamurthi, L., & Zoltners, A. (1994). Analysis of new product diffusion using a four-segment trial-repeat model. Marketing Science, 13(3), 224-247.
30. Hauser, J. R., Tellis, G. J., & Griffin, A. (2006). Research on innovation: a review and agenda for future research. Marketing Science, 25(6), 687-717.
31. Hill, R. C., & Adkins, L. C. (2003). Collinearity. In B. H. Baltagi (Ed.), A companion to theoretical econometrics. Malden: Blackwell.
32. Horsky, D., & Simon, L. L. (1983). Advertising and the diffusion of new products. Marketing Science, 2(1), 1-18.
33. Kalyanaram, G., & Urban, G. L. (1992). Dynamic effects of order-of-entry on market share, trial penetration, and repeat purchases for frequently purchased consumer goods. Marketing Science, 11(3), 235-250.
34. Kalyanaram, G., Robinson, W. T., & Urban, G. L. (1995). Order of market entry: established empirical generalizations, emerging empirical generalizations, and future research. Marketing Science, 14(3/2), G212-G221.
35. Kalyanaraman, G., & Wittink, D. R. (1994). Heterogeneity in entry effets between nondurable consumer product categories. International Journal of Research in Marketing, 11(3), 219-231.
36. Kornelis, M., Dekimpe, M. G., & Leeflang, P. S. H. (2008). Does competitive entry structurally change key marketing metrics. International Journal of Research in Marketing, 25(3), 173-182.
37. Kremer, S. T. M., Bijmolt, T. H. A., Leeflang, P. S. H., & Wieringa, J. E. (2008). Generalizations on the effectiveness of pharmaceutical promotional expenditures. International Journal of Resesarch in Marketing, 25(4), 234-246.
38. Krishnan, T. V., Bass, F. M., & Kumar, V. (2000). Impact of a late entrant on the diffusion of a new product/service. Journal of Marketing Research, 37(2), 269-278.
39. Leenders, A. A. M., & Wierenga, B. (2008). The effect of the marketing-R&D interface on new product performance: the critical role of resources and scope. International Journal of Research in Marketing, 25, 56-68.
40. Lieberman, M. B., & Montgomery, D. B. (1988). First-mover advantages. Strategic Management Journal, 9, 41-58.
41. Lilien, G. L., Rao, A. G., & Kalish, S. (1981). Bayesian estimation and control of detailing effort in a repeat purchase diffusion environment. Management Science, 27(5), 493-506.
42. Mahajan, V., Muller, E., & Bass, F. M. (1990). New product diffusion models in marketing: a review and directions for research. Journal of Marketing, 54(1), 1-26.
43. Manchanda, P., Wittink, D. R., Ching, A., Cleanthous, P., Ding, M., Dong, X. J., et al. (2005). Understanding firm, physician and consumer choice behavior in the pharmaceutical industry. Marketing Letters, 16(3/4), 293-308.
44. McAlister, L., & Pessemier, E. (1982). Variety seeking behavior: an interdisciplinary review. Journal of Consumer Research, 9(3), 311-322.
45. Neelameghan, R., & Chintagunta, P. K. (2004). Modeling and forecasting the sales of technology products. Quantitative Marketing & Economics, 2(3), 195-232.
46. Obeid, I., & Vine, P. (2005). Pharmaceutical industry: changing paradigms, changing opportunities. EJHPJournal, 11(4), 9. Available at www.eahponline.org/upload/ejhp/InthisIssue78-79.pdf.
47. Osinga, E. C., Leeflang, P. S. H., & Wieringa, J. E. (2010). Early marketing matters. Journal of Marketing Research, 47(1), 173-185.
48. Polli, R., & Cook, V. J., Jr. (1969). Validity of the product life cycle. Journal of Business, 42(4), 385-400.
49. Prins, R., & Verhoef, P. C. (2007). Marketing communication drivers of adoption timing of a new EService among existing customers. Journal of Marketing, 71(2), 169-183.
50. Rao, A. G., & Masataka, Y. (1988). Forecasting with a repeat purchase diffusion model. Management Science, 34(6), 734-752.
51. Robinson, W. T., & Fornell, C. (1985). Sources of market pioneer advantages in consumer goods industries. Journal of Marketing Research, 22(3), 305-317.
52. Rogers, E. M. (1995). Diffusion of innovations (4th ed.). New York: The Free.
53. Schmid, E. A., & Smith, D. A. (2002). Discovery, innovation and the cyclical nature of the pharmaceutical business. Drug Discovery Today, 7(10), 563-568.
54. Shankar, V., Carpenter, G. S., & Krishnamurthi, L. (1998). Late mover advantage: how innovative late entrants outsell pioneers. Journal of Marketing Research, 35(1), 54-70.
55. Shankar, V., Carpenter, G. S., & Krishnamurthi, L. (1999). The advantages of entry in the growth stage of the product life cycle: an empirical analysis. Journal of Marketing Research, 36(2), 269-276.
56. Simon, H. (1979). Dynamics of price elasticities and brand life cycles: an empirical study. Journal of Marketing Research, 16(4), 439-452.
57. Srivastava, R. K., Shervani, T. A., & Fahey, L. (1998). Market based assets and shareholder value: a framework for analysis. Journal of Marketing, 62(1), 2-18.
58. Steenkamp, J. B. E. M., & Gielens, K. (2003). Consumer and market drivers of the trial probability of new consumer packaged goods. Journal of Consumer Research, 30(3), 368-384.
59. Stremersch, S., & Tellis, G. J. (2004). Understanding and managing growth of international new products. International Journal of Research in Marketing, 21(4), 421-438.
60. Stremersch, S., & van Dyck, W. (2009). Marketing of the life sciences: a new framework and research agenda for a nascent field. Journal of Marketing, 73, 4-30.
61. Suresh, P., Basu P. K., & Venkatsasbramanian, V. (2006). Impact of improving pharmaceutical product development and manufacturing. Presentation for AICHE 2006, Purdue University.
62. Tellis, G. J., & Johnson, J. (2007). The value of quality. Marketing Science, 26(6), 758-773.
63. Tellis, G. J., Stremersch, S., & Yin, E. (2003). The international takeoff of new products: the role of economics, culture, and country innovativeness. Marketing Science, 22(2), 188-208.
64. Tradingmarkets.com (2007). Shares of Salix pharmaceuticals tumble; downgraded to sell at Piper Jaffray, available at http://www.tradingmarkets.com/.site/news/Stock%20News/948264/ (Accessed at 1/22/2008).
65. Urban, G. L., Carter, T., Gaskin, S., & Mucha, Z. (1986). Market share rewards to pioneering brands: an empirical analysis and strategic implications. Management Science, 32(6), 645-659.
66. Venkataraman, S., & Stremersch, S. (2007). The debate on influencing doctors’ decisions: are drug characteristics the missing link? Management Science, 53(11), 1688-1701.
67. von Bertalanffy, L. (1957). Quantitative laws in metabolism and growth. Quarterly Review of Biology, 32, 217-231.
68. Zhang, J., & Narasimhan, C. (2000). Market entry strategy under firm heterogeneity and symmetric payoffs. Marketing Science, 19(4), 313-327.